What is it about?
This chapter explores the growing field of halal pharmaceuticals—medicines that comply with Islamic law by avoiding prohibited substances such as alcohol and pork-derived ingredients. It examines how religious beliefs influence patients’ choices, the challenges faced by healthcare professionals, and how the pharmaceutical industry is responding to increasing demand. The chapter highlights key issues such as limited awareness among patients and healthcare providers, gaps in education and training, and the complexity of identifying halal-compliant ingredients in modern medicines. It also discusses global differences in halal certification and regulation, which can create confusion and inconsistency. A major focus is on education—both in universities and in professional training—to better prepare pharmacists and clinicians to address patients’ religious concerns. The chapter also explains important ethical principles in Islamic bioethics, including the concept of necessity (darurah), which allows the use of otherwise prohibited substances in life-saving situations. Overall, the chapter shows how halal pharmaceuticals sit at the intersection of religion, science, and healthcare, and calls for better collaboration, education, and regulation to support patient-centered care.
Featured Image
Photo by Roman Kraft on Unsplash
Why is it important?
This work is important because it addresses a rapidly growing but underdeveloped area in global healthcare. As the Muslim population continues to increase, so does the demand for medicines that align with religious values—but healthcare systems are not fully prepared to meet this need. The chapter highlights critical gaps in education, regulation, and clinical practice that can affect patient trust, treatment adherence, and health outcomes. It also shows that misunderstanding or ignoring halal concerns can lead to patients refusing medication or delaying care. What makes this work unique is its integration of three key dimensions: education, real-world practice, and Islamic pharmaceutical ethics. It goes beyond identifying problems and proposes practical solutions, including curriculum reform, professional training, global regulatory harmonization, and stronger collaboration between scientists and religious scholars. By framing halal pharmaceuticals as part of culturally competent and ethical healthcare, this work contributes to building a more inclusive, transparent, and patient-centered healthcare system.
Perspectives
Working on this chapter allowed me to move beyond discussing halal pharmaceuticals as a technical issue (about ingredients), and instead engage with it as a space for ethical innovation (the realities of modern healthcare systems like trust and communication). I was particularly interested in exploring how Islamic bioethics can be creatively reinterpreted in light of contemporary challenges—especially in areas like pharmaceutical patents, access to medicines, and the moral limits of ownership. Bringing together concepts such as necessity, intellectual property, and justice pushed me to think about ethics not as static rules, but as a living, evolving framework. Equally compelling was the idea of the pharmaceutical scientist not as a passive expert, but as a co-participant in ethical reasoning contributing to how decisions are shaped at the intersection of science, law, and faith. For me, this work represents an attempt to merge disciplines that are too often separated: ethics and regulation, science and jurisprudence, innovation and responsibility.
Dr. Hisham E. Hasan
Jordan University of Science and Technology
Read the Original
This page is a summary of: Issues on Halal Pharmaceuticals: Education, Practice, and Islamic Pharmaceutical Ethics, January 2026, Springer Science + Business Media,
DOI: 10.1007/978-981-95-6378-4_8.
You can read the full text:
Contributors
The following have contributed to this page
